Sonoma Pharmaceuticals
SNOA
#10267
Rank
A$5.64 M
Marketcap
$4.21
Share price
0.00%
Change (1 day)
-13.14%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -A$6.39 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are A$13.54 Million. In 2023 the company made an earning of -A$7.06 Million, an increase over its 2022 earnings that were of -A$10.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$6.39 Million-9.59%
2023 -A$7.06 Million-31.5%
2022 -A$10.31 Million16.86%
2021 -A$8.82 Million194.32%
2020 -A$3 Million-58.76%
2019 -A$7.27 Million-65.66%
2018 -A$21.16 Million4.84%
2017 -A$20.19 Million-2.17%
2016 -A$20.63 Million32.12%
2015 -A$15.62 Million-307.74%
2014 A$7.51 M-197.5%
2013 -A$7.71 Million
2010 -A$12.05 Million-14.02%
2009 -A$14.01 Million-57.28%
2008 -A$32.79 Million-8.03%
2007 -A$35.66 Million3.85%
2006 -A$34.33 Million39.31%
2005 -A$24.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$28.88 Million 324.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion 2,655.87%๐Ÿ‡บ๐Ÿ‡ธ USA